home / stock / dcph / dcph quote
Last: | $25.59 |
---|---|
Change Percent: | 100.0% |
Open: | $0 |
Close: | $25.59 |
High: | $0 |
Low: | $0 |
Volume: | 16 |
Last Trade Date Time: | 12/31/1969 07:00:00 pm |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$25.59 | $0 | $25.59 | $0 | $0 | 16 | 06-28-2024 |
$25.59 | $0 | $25.59 | $0 | $0 | 2,200 | 06-18-2024 |
$25.59 | $0 | $25.59 | $0 | $0 | 2,200 | 06-17-2024 |
$25.59 | $25.56 | $25.59 | $25.61 | $25.56 | 1,596,089 | 06-10-2024 |
$25.57 | $25.57 | $25.57 | $25.58 | $25.56 | 506,790 | 06-07-2024 |
$25.55 | $25.58 | $25.55 | $25.58 | $25.55 | 1,223,851 | 06-06-2024 |
$25.58 | $25.57 | $25.58 | $25.59 | $25.55 | 2,012,711 | 06-05-2024 |
$25.57 | $25.56 | $25.57 | $25.57 | $25.55 | 510,524 | 06-04-2024 |
$25.56 | $25.56 | $25.56 | $25.57 | $25.54 | 1,415,926 | 06-03-2024 |
$25.54 | $25.52 | $25.54 | $25.56 | $25.52 | 1,854,493 | 05-31-2024 |
$25.53 | $25.53 | $25.53 | $25.54 | $25.51 | 701,005 | 05-30-2024 |
$25.51 | $25.51 | $25.51 | $25.53 | $25.51 | 1,062,075 | 05-29-2024 |
$25.51 | $25.52 | $25.51 | $25.54 | $25.51 | 1,089,394 | 05-28-2024 |
$25.51 | $25.52 | $25.51 | $25.53 | $25.51 | 553,791 | 05-27-2024 |
$25.51 | $25.52 | $25.51 | $25.53 | $25.51 | 553,791 | 05-24-2024 |
$25.5 | $25.52 | $25.5 | $25.52 | $25.49 | 1,060,832 | 05-23-2024 |
$25.48 | $25.53 | $25.48 | $25.53 | $25.47 | 1,755,548 | 05-22-2024 |
$25.47 | $25.46 | $25.47 | $25.49 | $25.46 | 1,075,181 | 05-21-2024 |
$25.47 | $25.47 | $25.47 | $25.48 | $25.45 | 851,175 | 05-20-2024 |
$25.46 | $25.46 | $25.46 | $25.47 | $25.44 | 1,152,881 | 05-17-2024 |
News, Short Squeeze, Breakout and More Instantly...
Deciphera Pharmaceuticals Inc. Company Name:
DCPH Stock Symbol:
NASDAQ Market:
Deciphera Pharmaceuticals Inc. Website:
– MOTION Phase 3 Data Demonstrate Robust Efficacy, Clinically Meaningful Improvements in Quality-of-Life Measures, and Well-Tolerated Safety Profile, Positioning Vimseltinib as Potential New TGCT Treatment – – Company Expects to Submit a New Drug Application (NDA) in ...
Apartment Investment and Management Company (AIV) is expected to report for Q1 2024 Shopify Inc. Class A Subordinate (SHOP) is expected to report $0.08 for Q1 2024 Beyond Meat Inc. (BYND) is expected to report $-0.68 for Q1 2024 Instructure Holdings Inc. (INST) is expected to report $...